Stablepoint Partners’s Eli Lilly LLY Stock Holding History

Stablepoint Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.89M	Sell	3,240 -53	-2%	-$54.2K	0.54%	65
2026 Q1	$3.03M	Sell	3,293 -27	-0.8%	-$27.4K	0.45%	73
2025 Q4	$3.57M	Sell	3,320 -47	-1%	-$44.9K	0.56%	60
2025 Q3	$2.57M	Buy	3,367 +91	+3%	+$67.7K	0.41%	79
2025 Q2	$2.55M	Sell	3,276 -79	-2%	-$61.4K	0.43%	77
2025 Q1	$2.77M	Buy	3,355 +143	+4%	+$119K	0.5%	67
2024 Q4	$2.48M	Sell	3,212 -127	-4%	-$105K	0.46%	69
2024 Q3	$2.96M	Sell	3,339 -147	-4%	-$132K	0.54%	61
2024 Q2	$2.82M	Sell	3,486 -51	-1%	-$40.8K	0.55%	62
2024 Q1	$2.75M	Buy	3,537 +779	+28%	+$554K	0.56%	61
2023 Q4	$1.61M	Buy	+2,758	New	+$1.61M	0.41%	71

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Stablepoint Partners's LLY Position: Q2 2026 in Review

Stablepoint Partners reduced its Eli Lilly (LLY) stake by 1.6% in Q2 2026, selling an estimated $54.2K and leaving 3,240 shares worth $3.89M. The position accounts for 0.54% of the portfolio, ranked #65.

Stablepoint Partners first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 1,842 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Stablepoint Partners held 3,240 shares of Eli Lilly worth $3.89M as of Q2 2026.
Stablepoint Partners sold 53 Eli Lilly shares in Q2 2026, an estimated $54.2K.
Eli Lilly made up 0.54% of Stablepoint Partners's portfolio in Q2 2026, its #65 holding.
Stablepoint Partners first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
1,842 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Stablepoint Partners's 13F filing for Q2 2026, filed 9 Jul 2026.